Abstract
Objective
To assess the effect of angiotensin II type 1 (AT1) receptor antagonist losartan on myocardium connexin43 (Cx43) gap junction (GJ) expression in spontaneously hypertensive rats (SHRs) and investigate possible mechanisms.
Methods
Sixteen 9-week-old male SHRs and 8 age-matched male Wistar-Kyoto (WKY) rats were included in this study. SHRs were randomly divided into two groups to receive losartan at 30 mg/(kg·d) by oral gavage once daily for 8 weeks (SHR-L) or vehicle (0.9% saline) to act as controls (SHR-V); WKY rats receiving vehicle for 8 weeks served as normotensive controls. At the end of the experiment, rats were sacrificed and the hearts were removed. Expressions of Cx43 and nuclear factor-kappaB p65 (NF-κB p65) proteins in all three groups were observed and further investigations on the effect of angiotensin II type 1 receptor antagonist losartan (30 mg/(kg·d), 8 weeks) on Cx43 expression were conducted with Western blot and immunohistochemistry. NF-κB p65 protein in nuclear extracts was determined by Western blot.
Results
Left ventricular (LV) hypertrophy was prominent in SHRs, Cx43 and NF-κB p65 protein expressions were obviously upregulated and Cx43 distribution was dispersed over the cell surface. Treatment with losarton reduced the over-expressions of Cx43 and NF-κB p65 in LV myocardium. The distribution of Cx43 gap junction also became much regular and confined to intercalated disk after losartan treatment.
Conclusion
Cx43 level was upregulated in LV myocardium of SHR during early stage of hypertrophy. Angiotensin II type 1 receptor antagonist losartan prevented Cx43 gap junction remodeling in hypertrophied left ventricles, possibly through the NF-κB pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cai, W., Ruan, L.M., Wang, Y.N., Chen, J.Z., 2006. Effects of angiotensin II on connexin43 of VSMCs in arteriosclerosis. J. Zhejiang Univ. Sci. B, 7(8):648–653. [doi:10.1631/jzus.2006.B0648]
Dahlof, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., 2002. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet, 359(9311):995–1003. [doi:10.1016/S0140-6736(02)08089-3]
Dodge, S.M., Beardslee, M.A., Darrow, B.J., Green, K.G., Beyer, E.C., Saffitz, J.E., 1998. Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes. J. Am. Coll. Cardiol., 32(3):800–807. [doi:10.1016/S0735-1097(98)00317-9]
Emdad, L., Uzzaman, M., Takagshi, Y., Honjo, H., Uchida, T., Severs, N.J., Kodama, I., Murata, Y., 2001. Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. J. Mol. Cell. Cardiol., 33(2):219–231. [doi:10.1006/jmcc.2000.1293]
Gupta, S., Purcell, N.H., Lin, A., Sen, S., 2002. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J. Cell Biol., 159(6):1019–1028. [doi:10.1083/jcb.200207149]
Hirotani, S., Otsu, K., Nishida, K., Higuchi, Y., Morita, T., Nakayama, H., Yamaguchi, O., Mano, T., Matsumura, Y., Ueno, H., 2002. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyote hypertrophy. Circulation, 105(4):509–515. [doi:10.1161/hc0402.102863]
Jiang, Y.G., Jiang, R., Jin, J., Wang, H.P., Chen, J.H., 2006. Changes of gap junction in penile cavernous smooth muscle cells of hypertensive rats. Zhonghua Nan Ke Xue, 12(11):1010–1013 (in Chinese).
Litchenberg, W.H., Norman, L.W., Holwell, A.K., Martin, K.L., Hewett, K.W., Gourdie, R.G., 2000. The rate and anisotrophy of impulse propagation in the postnatal terminal crest are correlated with remodeling of Cx43 gap junction pattern. Cardiovasc. Res., 45(2):379–387. [doi:10.1016/S0008-6363(99)00363-6]
Mondry, A., Svynghedauw, B., 1995. Biological adaptation of the myocardium to chronic mechanical overload. Molecular determinants of the autonomic nervous system. Eur. Heart. J., 16(Suppl. 1):64–73.
Peters, N.S., Green, C.R., Poole-Wilson, P.A., Severs, N.J., 1993a. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation, 88(3):864–875.
Peters, N.S., del Monte, F., MacLeod, K.T., Green, C.R., Poole-Wilson, P.A., Severs, N.J., 1993b. Increased cardiac myocyte gap-junctional membrane early in renovascular hypertension. Am. J. Cardiol., 21:59A (Abstracts).
Pimentel, R.C., Yamada, K.A., Klebr, A.G., Saffitz, J.E., 2002. Autocrine regulation of myocyte Cx43 expression by VEGF. Circ. Res., 90(6):671–677. [doi:10.1161/01.RES.0000014823.75393.4D]
Polontchouk, L., Haefliger, J.A., Ebelt, B., Schaefer, T., Stuhlmann, D., Mehlhorn, U., Kuhn-Regnier, F., de Vivie, E.R., Dhein, S., 2001. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J. Am. Coll. Cardiol., 38(3):883–891. [doi:10.1016/S0735-1097(01)01443-7]
Polontchouk, L., Ebelt, B., Jackeis, M., Dhein, S., 2002. Chronic effect of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J., 16(1):87–89.
Purcell, N.H., Tang, G., Yu, C., Mercurio, F., Di Donato, J.A., Lin, A., 2001. Activation of NF-kappaB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. USA, 98(12):6668–6673. [doi:10.1073/pnas.111155798]
Saffitz, J.E., Schuessler, R.B., Yamada, K.A., 1999. Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. Cardiovasc. Res., 42(2):309–317. [doi:10.1016/S00086363(99)00023-1]
Severs, N.J., 1999. Cardiovascular disease. Novartis Found Symp., 219:188–211.
Severs, N.J., Coppen, S.R., Dupont, E., Yeh, H.I., Ko, Y.S., Matsushita, T., 2004. Gap junction alterations in human cardiac disease. Cardio. Res., 62(2):368–377. [doi:10.1016/j.cardiores.2003.12.007]
Shyu, K.G., Chen, C.C., Wang, B.W., Kuan, P., 2001. Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol., 33(4):691–698. [doi:10.1006/jmcc.2000.1333]
Uzzaman, M., Honji, H., Takagishi, Y., Emad, L., Anthoy, I., Magee, A.I., Severs, N.J., Kodama, I., 2000. Remodelling of gap junctional coupling of rats with monocrotaline-induced pulmonary hypertension. Circ. Res., 86(8):871–878.
Vakili, B.A., Okin, P.M., Devereux, R.B., 2001. Prognostic implications of left ventricular hypertrophy. Am. Heart J., 141(3):334–341. [doi:10.1067/mhj.2001.113218]
Yeh, H.I., Lee, P.Y., Su, C.H., Tian, T.Y., Ko, Y.S., Tsai, C.H., 2006. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am. J. Hypertens., 19(2):129–135. [doi:10.1016/j.amjhyper.2005.08.020]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, Ll., Chen, Hj., Chen, Jz. et al. Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive rats. J. Zhejiang Univ. Sci. B 9, 448–454 (2008). https://doi.org/10.1631/jzus.B0820050
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B0820050
Key words
- Connexin43 (Cx43)
- Left ventricular (LV) hypertrophy
- Angiotensin II
- Nuclear factor-kappaB p65 (NF-κB p65)
- Gap junction (GJ)